Article
Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
mSphere - 25 Aug 2021
Chen Liang, Zody Michael C, Di Germanio Clara, Martinelli Rachel, Mediavilla Jose R, Cunningham Marcus H, Composto Kaelea, Chow Kar Fai, Kordalewska Milena, Corvelo André, Oschwald Dayna M, Fennessey Samantha, Zetkulic Marygrace, Dar Sophia, Kramer Yael, Mathema Barun, Germer Soren, Stone Mars, Simmons Graham, Busch Michael P, Maniatis Tom, Perlin David S, Kreiswirth Barry N
Abstract excerpt
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs), harboring spike protein N-terminal domain (NTD) or receptor-binding domain (RBD) mutations, exhibit reduced in vitro susceptibility to convalescent-phase serum, commercial antibody cocktails, and vaccine neutralization and have been associated with reinfections. The accumulation of these mutations could be the consequence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
